Pharmacological management of male breast cancer
- 4 June 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Opinion on Pharmacotherapy
- Vol. 21 (12), 1493-1504
- https://doi.org/10.1080/14656566.2020.1763305
Abstract
Despite its rarity, male breast cancer shows a steadily rising incidence. Given the absence of ad hoc prospective randomized clinical trials, treatment strategies are based on extrapolation from female breast cancer recommendations or solely on population-based data. This review discusses the current treatment landscape for male breast cancer in the adjuvant and in the metastatic setting. The authors also discuss the biology and genomic landscape of male breast cancer. Original research and review articles, relative to the period 2010–2019, were included in the review of the literature. There is a major medical need to include male patients with breast cancer in prospective clinical trials. The call to equality in breast cancer care can be pursued via two divergent paths: (i) a gender-neutral delivery of breast cancer information and (ii) the creation of separate sections, for the more common female breast cancer and for the rare male ones. We propose to differentiate male breast cancer care, acknowledging unique onco-sexual and social needs that can be only partially shared.This publication has 105 references indexed in Scilit:
- Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy RadiotherapyBreast Care, 2013
- Molecular subtyping of male breast cancer by immunohistochemistryLaboratory Investigation, 2012
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast CancerThe New England Journal of Medicine, 2012
- Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effectsAnnals of Oncology, 2011
- Breast cancer in men in the United StatesCancer, 2010
- Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cellsBreast Cancer Research and Treatment, 2009
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate CancerScience, 2009
- Adjuvant systemic therapy for male breast carcinomaCancer, 2005
- Male breast cancer: a 22-year experienceEuropean Journal of Surgical Oncology, 1998
- A review of the management of the male breast carcinoma based on an analysis of 420 treated casesThe Breast, 1996